The Regional Expert Committee on Traditional Medicine for COVID-19 hopes that the phase-3 clinical trials of herbal medicines will begin in October.

The committee was formed by the World Health Organization (WHO), the Africa Centre for Disease Control and Prevention and the African Union Commission for Social Affairs.

The panel has endorsed the protocol for phase-3 clinical trials as well as a charter and terms of reference for the establishment of a data and safety monitoring board. If a traditional medicine product is found to be safe, efficacious, and quality-assured, the WHO will recommend for a fast-tracked, large-scale local manufacturing.

Dr Ossy Kasilo, the WHO Regional Adviser for the Traditional Medicine programme shares more: